Pharmacokinetics of unchanged carboplati
โ
Phillip A. Reece; James F. Bishop; Ian N. Olver; Irene Stafford; Brian L. Hilloc
๐
Article
๐
1987
๐
Springer
๐
English
โ 476 KB
The disposition of the cisplatin analogue carboplatin was studied in seven patients with small cell lung cancer. Carboplatin 100 mg/m2 was administered without hydration by a 1-h infusion with VP16-213 120 mg/m2 on days 1, 2 and 3 of each course. Plasma and urine collections were made on days 1 and